(lp0
S"Why Portola Pharmaceuticals Inc Stock Surged Higher Today Motley Fool - Dec 23, 2016 Shares of clinical stage anticoagulant specialist Portola Pharmaceuticals Inc  rose 33.5% at the end of Friday's session.Portola Shares Surge on Application Acceptance - Wall Street Journal"
p1
aS"Equity Perception: Analyst's Indicator Review for Portola Pharmaceuticals, Inc ... The USA Commerce - 17 hours ago Presently Portola Pharmaceuticals, Inc.  stock have an ABR of 1.13. This is built on a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.Risk-Adjusted Valuation Of Portola Pharmaceuticals Shows Significant Upside - Seeking AlphaCowen and Company Increases Portola Pharmaceuticals Inc  Price Target to ... - Chaffey Breeze"
p2
aS'Portola Pharmaceuticals Inc.  Plunges 6.04% on March 21 Equities.com - Mar 21, 2017 Portola Pharmaceuticals Inc.  had a rough trading day for Tuesday March 21 as shares tumbled 6.04%, or a loss of $-2.44 per share, to close at $37.98.'
p3
aS"Portola Pharmaceuticals Reports Fourth Quarter and Year-End 2016 Financial ... GlobeNewswire  - Feb 28, 2017 Collaboration and license revenue earned under Portola's collaboration and license agreements with Bristol-Myers Squibb Company and Pfizer, Bayer Pharma and Janssen Pharmaceuticals, Daiichi Sankyo and Dermavant Sciences was $13.7 million for the&nbsp;...Portola Pharmaceuticals Inc.  Moves Higher on Volume Spike for March 01 - Equities.com"
p4
aS"Portola Pharmaceuticals Announces Betrixaban and AndexXa (andexanet alfa ... GlobeNewswire  - Mar 7, 2017 SOUTH SAN FRANCISCO, Calif., March 07, 2017  -- Portola Pharmaceuticals Inc.  today announced that new data from the pivotal Phase 3 APEX Study of the Company's investigational drug betrixaban will be&nbsp;...Lookout for Price Target? Molina Healthcare, Inc. , Portola ... - StockNewsJournal"
p5
aS"Portola Pharmaceuticals to Announce Fourth Quarter and Year-End 2016 Financial ... Yahoo Finance - Feb 21, 2017 21, 2017  -- Portola Pharmaceuticals, Inc.  announced today that it will host a webcast and conference call to discuss the Company's financial results for the quarter and year ended December 31, 2016, and provide a general&nbsp;...Portola Pharmaceuticals Inc.  Breaks into New 52-Week High on February ... - Equities.com"
p6
aS'Portola Pharmaceuticals Reaches Analyst Target Price Nasdaq - Feb 22, 2017 In recent trading, shares of Portola Pharmaceuticals, Inc.  have crossed above the average analyst 12-month target price of $32.33, changing hands for $32.66/share.'
p7
aS'Market Check: Narrowing in on Shares of Portola Pharmaceuticals, Inc. (NASDAQ ... Baldwin Journal - 16 hours ago Some individuals may be looking to monitor stock price momentum by looking at different historical data. Portola Pharmaceuticals, Inc.  currently has a 6 month price index of 1.60118. The six month price index is simply measured by ...'
p8
aS"Portola Pharmaceuticals Inc.  Breaks into New 52-Week High on March 15 ... Equities.com - Mar 15, 2017 Shares of Portola Pharmaceuticals Inc.  broke into a new 52-week high yesterday, hitting a peak of $40.92. Shares closed at $40.86 after opening at $39.59 for a move of 3.26%.Portola Pharmaceuticals, Inc. : Important Trade and Target Levels ... - Post AnalystToday's Brokerage Rating: HealthSouth Corporation , Portola ... - StockNewsJournal"
p9
aS"Today's Brokerage Rating: Regal Entertainment Group , Portola ... StockNewsJournal - Mar 20, 2017 Portola Pharmaceuticals, Inc. , maintained return on investment for the last twelve months at -74.02, higher than what Reuters data shows regarding industry's average."
p10
a.